The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Alzheimer's Drugs – A Global Market Overview
US$ 4,500.00
Alzheimer's Drugs Market Trends and Outlook Alzheimer's disease is a degenerative neurological condition that progresses over time and is the primary cause of dementia, typically impacting individuals...
September 2024
253 pages
Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029
US$ 2,970.00
The Age-Related Macular Degeneration (AMD) Drugs market is projected to reach USD 17.37 Billion from 2029 USD 10.46 Billion in 2024 growing at a CAGR of 10.7% during the forecast period of 2024-2029....
September 2024
336 pages
Vitamin D Therapy Market - 2024-2031
US$ 3,400.00
Vitamin D Therapy Marketis is growing with a CAGR of 12.20% during the forecast period 2026-2035. The Vitamin D Therapy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, wh...
September 2024
43 pages
Anticoagulation Therapy Market - 2024-2031
US$ 3,400.00
The Anticoagulation Therapy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...
September 2024
49 pages
Aplastic Anemia Market - 2024-2031
US$ 3,400.00
The Aplastic Anemia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparall...
September 2024
41 pages
Alpha-mannosidosis Treatment Market - 2024-2031
US$ 3,400.00
The Alpha-mannosidosis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...
September 2024
54 pages
Iron Overload Syndrome Treatment Market - 2024-2031
US$ 3,400.00
The Iron Overload Syndrome Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...
September 2024
58 pages
Penicillin Drug Market - 2024-2031
US$ 3,400.00
Penicillin Drug Marketis is growing with a CAGR of 4.40% during the forecast period 2026-2035. The Penicillin Drug Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where s...
September 2024
41 pages
Primary Hyperoxaluria Treatment Market - 2024-2031
US$ 3,400.00
Primary Hyperoxaluria Treatment Market reached US$ 168.96 million in 2023 and is expected to reach US$ 365.49 million by 2031, growing with a CAGR of 9.80% during the forecast period 2026-2031. The Pr...
September 2024
57 pages
Endometriosis Drug Market - 2024-2031
US$ 3,400.00
Endometriosis Drug Marketis is growing with a CAGR of 10.40% during the forecast period 2026-2035. The Endometriosis Drug Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
September 2024
44 pages
Cetirizine Hydrochloride Market - 2024-2031
US$ 3,400.00
Cetirizine Hydrochloride Market reached US$ 6,797.9 million in 2023 and is expected to reach US$ 8,882.5 million by 2031, growing with a CAGR of 3.40% during the forecast period 2026-2031. The Cetiriz...
September 2024
50 pages
Antibody Drugs: Technologies and Global Markets
US$ 4,650.00
... growth rate (CAGR) of 6.3% from 2017 through 2022. The global antibody drugs market for autoimmune diseases reached $37.3 billion in 2016. The market ... $37.5 billion in 2017, at a CAGR of 5.1% from 2017 through 2022. The global antibody drugs market for lymphoma reached $37.3 billion in 2016. The market should ...
September 2024
156 pages
Hazardous Drug Administration Market - 2024-2031
US$ 3,400.00
Hazardous Drug Administration Market reached US$ 459.5 million in 2023 and is expected to reach US$ 1900.9 million by 2031, growing with a CAGR of 20.20% during the forecast period 2026-2031. The Haza...
September 2024
55 pages
Osteoporosis Drugs Market - 2024-2031
US$ 3,400.00
Osteoporosis Drugs Market reached US$ 14,066.4 million in 2022 and is expected to reach US$ 19,336.6 million by 2031, growing with a CAGR of 4.10% during the forecast period 2026-2031. The Osteoporosi...
September 2024
44 pages
Drug Discovery Technologies
US$ 4,650.00
... among others. Key players in the drug discovery market include Thermo Fisher Scientific, Agilent Technologies Inc., Shimadzu Corp., Bruker Corp., ... 23 additional tables. An overview of the global markets for drug discovery technologies. Analyses of global market trends with data from 2015, 2016, and 2017, ...
September 2024
192 pages
Post Menopausal Osteoporosis Market - 2024-2031
US$ 3,400.00
Post Menopausal Osteoporosis Market reached US$ 9.9 billion in 2023 and is expected to reach US$ 15.2 billion by 2031, growing with a CAGR of 5.40% during the forecast period 2026-2031. The Post Menop...
September 2024
54 pages
G7 Spinocerebellar Ataxia Market - 2024-2031
US$ 3,400.00
G7 Spinocerebellar Ataxia Marketis is growing with a CAGR of 6.30% during the forecast period 2026-2035. The G7 Spinocerebellar Ataxia Market emerges as a key focus in DataM Intelligence latest in-dep...
August 2024
51 pages
Water Treatment Aerators Market - 2024-2031
US$ 3,400.00
Water Treatment Aerators Marketis is growing with a CAGR of 6.90% during the forecast period 2026-2035. The Water Treatment Aerators Market emerges as a key focus in DataM Intelligence latest in-depth...
August 2024
50 pages
Erectile Dysfunction Drugs Market - 2024-2031
US$ 3,400.00
Erectile Dysfunction Drugs Market reached US$ 3.5 billion in 2023 and is expected to reach US$ 5.0 billion by 2031, growing with a CAGR of 4.70% during the forecast period 2026-2031. The Erectile Dysf...
August 2024
52 pages
Gastroparesis Drugs Market - 2024-2031
US$ 3,400.00
Gastroparesis Drugs Marketis is growing with a CAGR of 4.90% during the forecast period 2026-2035. The Gastroparesis Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
August 2024
45 pages
UAE Over the Counter (OTC) Drugs Market By Product Type (Cough, Cold and Flu, Vitamins, Mineral, and Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others), By Route of Administration (Oral, Topical, Parenteral), By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2019-2029F
US$ 3,500.00
UAE Over the Counter (OTC) Drugs Market was valued at USD 2.79 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 5.73% through 2029. Over the Cou...
August 2024
83 pages
Primary Immunodeficiency Diseases Market - 2024-2031
US$ 3,400.00
Primary Immunodeficiency Diseases Market reached US$ 7.3 billion in 2023 and is expected to reach US$ 13.0 billion by 2031, growing with a CAGR of 7.60% during the forecast period 2026-2031. The Prima...
August 2024
59 pages
Cytomegalovirus Infection Treatment Market - 2024-2031
US$ 3,400.00
Cytomegalovirus Infection Treatment Marketis is growing with a CAGR of 6.70% during the forecast period 2026-2035. The Cytomegalovirus Infection Treatment Market emerges as a key focus in DataM Intell...
August 2024
61 pages
Familial Lipoprotein Lipase Deficiency Market - 2024-2031
US$ 3,400.00
The Familial Lipoprotein Lipase Deficiency Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresi...
August 2024
64 pages
Pain Management Alternatives Market - 2024-2031
US$ 3,400.00
Pain Management Alternatives Market reached US$ 7.31 billion in 2023 and is expected to reach US$ 14.1 billion by 2031, growing with a CAGR of 8.60% during the forecast period 2026-2031. The Pain Mana...
August 2024
54 pages
Renal Fanconi Syndrome Market - 2024-2031
US$ 3,400.00
Renal Fanconi Syndrome Market reached US$ 576.4 million in 2023 and is expected to reach US$ 767.5 million by 2031, growing with a CAGR of 3.70% during the forecast period 2026-2031. The Renal Fanconi...
August 2024
48 pages
Artemisinin Combination Therapy Market - 2024-2031
US$ 3,400.00
Artemisinin Combination Therapy Market reached US$ 547 million in 2023 and is expected to reach US$ 1,061 million by 2031, growing with a CAGR of 8.80% during the forecast period 2026-2031. The Artemi...
August 2024
57 pages
Genitourinary Drugs Market - 2024-2031
US$ 3,400.00
Genitourinary Drugs Market reached US$ 31,220.0 million in 2023 and is expected to reach US$ 35,518.8 million by 2031, growing with a CAGR of 1.60% during the forecast period 2026-2031. The Genitourin...
August 2024
45 pages
Antinauseants Market - 2024-2031
US$ 3,400.00
Antinauseants Market reached US$ 2.3 billion in 2023 and is expected to reach US$ 3.7 billion by 2031, growing with a CAGR of 6.20% during the forecast period 2026-2031. The Antinauseants Market emerg...
August 2024
39 pages
Anti-Diarrheal Drugs Market - 2024-2031
US$ 3,400.00
The Anti-Diarrheal Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
July 2024
46 pages
Amyloidosis Treatment Market - 2024-2031
US$ 3,400.00
The Amyloidosis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver un...
July 2024
47 pages
Intravenous Iron Drugs Market - 2024-2031
US$ 3,400.00
Intravenous Iron Drugs Marketis is growing with a CAGR of 8.10% during the forecast period 2026-2035. The Intravenous Iron Drugs Market emerges as a key focus in DataM Intelligence latest in-depth ana...
July 2024
48 pages
Folinic Acid Market - 2024-2031
US$ 3,400.00
Folinic Acid Marketis is growing with a CAGR of 4.00% during the forecast period 2026-2035. The Folinic Acid Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasone...
July 2024
38 pages
Beta Inosine Market - 2024-2031
US$ 3,400.00
The Beta Inosine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparallele...
July 2024
38 pages
Immunotherapy Drugs Market Size, Share & Trends by Type (mAb, Checkpoint Inhibitor, Interferon, Cancer Vaccine), Application (Cancer, Autoimmune, Inflammatory, Hematology, Neurology), Route of Administration (Intravenous, Subcutaneous), End User - Global Forecast to 2029
US$ 2,970.00
... in the emerging markets, and immunotherapy as an alternative to chemotherapy for first line treatment are the factors supporting the growth of immunotherapy drugs market. Based on type of drugs, the market is segmented ... the largest market share in the immunotherapy drugs market, by type of drugs in 2016. On the other hand, checkpoint inhibitors segment is expected to be the fastest growing segment in the immunotherapy drugs market, by type of drugs, in 2016 ...
July 2024
335 pages
Antifungal Drugs Market - 2024-2031
US$ 3,400.00
Antifungal Drugs Marketis is growing with a CAGR of 3.30% during the forecast period 2026-2035. The Antifungal Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where...
July 2024
42 pages
Bacteriophages Therapy Market - 2024-2031
US$ 3,400.00
The Bacteriophages Therapy Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver u...
July 2024
48 pages
Drugs and Diagnostics for Hematological Disorders: Global Markets
US$ 4,650.00
This BCC Research report presents an analysis of the current state of hematological disorders and blood cancers, therapy and technology, and utilization of the various therapeutic and diagnostic modalities to prevent and treat these disorders. Forecast provided through 2020.
July 2024
133 pages
Anti-Obesity Drugs Market Report by Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs), Drug Type (Prescription Drugs, OTC Drugs), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032
US$ 2,999.00
The global anti-obesity drugs market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.3% du...
July 2024
146 pages
Hemorrhoid Treatment Devices Market - 2024-2031
US$ 3,400.00
The Hemorrhoid Treatment Devices Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...
June 2024
54 pages
Dravet Syndrome Therapeutics Market - 2024-2031
US$ 3,400.00
Dravet Syndrome Therapeutics Marketis is growing with a CAGR of 11.50% during the forecast period 2026-2035. The Dravet Syndrome Therapeutics Market emerges as a key focus in DataM Intelligence lates...
June 2024
55 pages
Japan Drugstore Market: Analysis By Product Category (Food, Household Utensils, Beauty Care, OTC Drugs, Dispensing, Health Care and Others), By Area of Operation (Stores with Floor Areas of 300m2 or Above and Stores with Floor Areas of Less Than 300m2), By Number of Stores, Size and Trends with Impact of COVID-19 and Forecast up to 2029
US$ 2,250.00
A drugstore is a retail store that offers prescription medications, over-the-counter (OTC) drugs, health and wellness products, personal care items, and often, groceries and household essentials. In J...
June 2024
95 pages
Polymyositis Drugs Market - 2024-2031
US$ 3,400.00
Polymyositis Drugs Market reached US$ 103.1 million in 2023 and is expected to reach US$ 132.6 million by 2031, growing with a CAGR of 3.20% during the forecast period 2026-2031. The Polymyositis Drug...
June 2024
44 pages
